Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients
BACKGROUND: Neurotropism of SARS-CoV-2 and its neurological manifestations have now been confirmed. We aimed at describing delirium and neurological symptoms of COVID-19 in ICU patients. METHODS: We conducted a bicentric cohort study in two French ICUs of Strasbourg University Hospital. All the 150...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414289/ https://www.ncbi.nlm.nih.gov/pubmed/32771053 http://dx.doi.org/10.1186/s13054-020-03200-1 |
_version_ | 1783568946116427776 |
---|---|
author | Helms, Julie Kremer, Stéphane Merdji, Hamid Schenck, Malika Severac, François Clere-Jehl, Raphaël Studer, Antoine Radosavljevic, Mirjana Kummerlen, Christine Monnier, Alexandra Boulay, Clotilde Fafi-Kremer, Samira Castelain, Vincent Ohana, Mickaël Anheim, Mathieu Schneider, Francis Meziani, Ferhat |
author_facet | Helms, Julie Kremer, Stéphane Merdji, Hamid Schenck, Malika Severac, François Clere-Jehl, Raphaël Studer, Antoine Radosavljevic, Mirjana Kummerlen, Christine Monnier, Alexandra Boulay, Clotilde Fafi-Kremer, Samira Castelain, Vincent Ohana, Mickaël Anheim, Mathieu Schneider, Francis Meziani, Ferhat |
author_sort | Helms, Julie |
collection | PubMed |
description | BACKGROUND: Neurotropism of SARS-CoV-2 and its neurological manifestations have now been confirmed. We aimed at describing delirium and neurological symptoms of COVID-19 in ICU patients. METHODS: We conducted a bicentric cohort study in two French ICUs of Strasbourg University Hospital. All the 150 patients referred for acute respiratory distress syndrome due to SARS-CoV-2 between March 3 and May 5, 2020, were included at their admission. Ten patients (6.7%) were excluded because they remained under neuromuscular blockers during their entire ICU stay. Neurological examination, including CAM-ICU, and cerebrospinal fluid analysis, electroencephalography, and magnetic resonance imaging (MRI) were performed in some of the patients with delirium and/or abnormal neurological examination. The primary endpoint was to describe the incidence of delirium and/or abnormal neurological examination. The secondary endpoints were to describe the characteristics of delirium, to compare the duration of invasive mechanical ventilation and ICU length of stay in patients with and without delirium and/or abnormal neurological symptoms. RESULTS: The 140 patients were aged in median of 62 [IQR 52; 70] years old, with a median SAPSII of 49 [IQR 37; 64] points. Neurological examination was normal in 22 patients (15.7%). One hundred eighteen patients (84.3%) developed a delirium with a combination of acute attention, awareness, and cognition disturbances. Eighty-eight patients (69.3%) presented an unexpected state of agitation despite high infusion rates of sedative treatments and neuroleptics, and 89 (63.6%) patients had corticospinal tract signs. Brain MRI performed in 28 patients demonstrated enhancement of subarachnoid spaces in 17/28 patients (60.7%), intraparenchymal, predominantly white matter abnormalities in 8 patients, and perfusion abnormalities in 17/26 patients (65.4%). The 42 electroencephalograms mostly revealed unspecific abnormalities or diffuse, especially bifrontal, slow activity. Cerebrospinal fluid examination revealed inflammatory disturbances in 18/28 patients, including oligoclonal bands with mirror pattern and elevated IL-6. The CSF RT-PCR SARS-CoV-2 was positive in one patient. The delirium/neurological symptoms in COVID-19 patients were responsible for longer mechanical ventilation compared to the patients without delirium/neurological symptoms. Delirium/neurological symptoms could be secondary to systemic inflammatory reaction to SARS-CoV-2. CONCLUSIONS AND RELEVANCE: Delirium/neurological symptoms in COVID-19 patients are a major issue in ICUs, especially in the context of insufficient human and material resources. TRIAL REGISTRATION: NA. |
format | Online Article Text |
id | pubmed-7414289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74142892020-08-10 Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients Helms, Julie Kremer, Stéphane Merdji, Hamid Schenck, Malika Severac, François Clere-Jehl, Raphaël Studer, Antoine Radosavljevic, Mirjana Kummerlen, Christine Monnier, Alexandra Boulay, Clotilde Fafi-Kremer, Samira Castelain, Vincent Ohana, Mickaël Anheim, Mathieu Schneider, Francis Meziani, Ferhat Crit Care Research BACKGROUND: Neurotropism of SARS-CoV-2 and its neurological manifestations have now been confirmed. We aimed at describing delirium and neurological symptoms of COVID-19 in ICU patients. METHODS: We conducted a bicentric cohort study in two French ICUs of Strasbourg University Hospital. All the 150 patients referred for acute respiratory distress syndrome due to SARS-CoV-2 between March 3 and May 5, 2020, were included at their admission. Ten patients (6.7%) were excluded because they remained under neuromuscular blockers during their entire ICU stay. Neurological examination, including CAM-ICU, and cerebrospinal fluid analysis, electroencephalography, and magnetic resonance imaging (MRI) were performed in some of the patients with delirium and/or abnormal neurological examination. The primary endpoint was to describe the incidence of delirium and/or abnormal neurological examination. The secondary endpoints were to describe the characteristics of delirium, to compare the duration of invasive mechanical ventilation and ICU length of stay in patients with and without delirium and/or abnormal neurological symptoms. RESULTS: The 140 patients were aged in median of 62 [IQR 52; 70] years old, with a median SAPSII of 49 [IQR 37; 64] points. Neurological examination was normal in 22 patients (15.7%). One hundred eighteen patients (84.3%) developed a delirium with a combination of acute attention, awareness, and cognition disturbances. Eighty-eight patients (69.3%) presented an unexpected state of agitation despite high infusion rates of sedative treatments and neuroleptics, and 89 (63.6%) patients had corticospinal tract signs. Brain MRI performed in 28 patients demonstrated enhancement of subarachnoid spaces in 17/28 patients (60.7%), intraparenchymal, predominantly white matter abnormalities in 8 patients, and perfusion abnormalities in 17/26 patients (65.4%). The 42 electroencephalograms mostly revealed unspecific abnormalities or diffuse, especially bifrontal, slow activity. Cerebrospinal fluid examination revealed inflammatory disturbances in 18/28 patients, including oligoclonal bands with mirror pattern and elevated IL-6. The CSF RT-PCR SARS-CoV-2 was positive in one patient. The delirium/neurological symptoms in COVID-19 patients were responsible for longer mechanical ventilation compared to the patients without delirium/neurological symptoms. Delirium/neurological symptoms could be secondary to systemic inflammatory reaction to SARS-CoV-2. CONCLUSIONS AND RELEVANCE: Delirium/neurological symptoms in COVID-19 patients are a major issue in ICUs, especially in the context of insufficient human and material resources. TRIAL REGISTRATION: NA. BioMed Central 2020-08-08 /pmc/articles/PMC7414289/ /pubmed/32771053 http://dx.doi.org/10.1186/s13054-020-03200-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Helms, Julie Kremer, Stéphane Merdji, Hamid Schenck, Malika Severac, François Clere-Jehl, Raphaël Studer, Antoine Radosavljevic, Mirjana Kummerlen, Christine Monnier, Alexandra Boulay, Clotilde Fafi-Kremer, Samira Castelain, Vincent Ohana, Mickaël Anheim, Mathieu Schneider, Francis Meziani, Ferhat Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients |
title | Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients |
title_full | Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients |
title_fullStr | Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients |
title_full_unstemmed | Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients |
title_short | Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients |
title_sort | delirium and encephalopathy in severe covid-19: a cohort analysis of icu patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414289/ https://www.ncbi.nlm.nih.gov/pubmed/32771053 http://dx.doi.org/10.1186/s13054-020-03200-1 |
work_keys_str_mv | AT helmsjulie deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT kremerstephane deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT merdjihamid deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT schenckmalika deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT severacfrancois deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT clerejehlraphael deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT studerantoine deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT radosavljevicmirjana deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT kummerlenchristine deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT monnieralexandra deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT boulayclotilde deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT fafikremersamira deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT castelainvincent deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT ohanamickael deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT anheimmathieu deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT schneiderfrancis deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients AT mezianiferhat deliriumandencephalopathyinseverecovid19acohortanalysisoficupatients |